首页|期刊导航|临床误诊误治|基于《备急千金要方》辛味药"辛能行散"理论透皮给药治疗膝骨关节炎寒湿痹阻证临床观察

基于《备急千金要方》辛味药"辛能行散"理论透皮给药治疗膝骨关节炎寒湿痹阻证临床观察OA

Clinical observation of transdermal delivery of pungent herbs for knee osteoarthritis with cold-dampness bi syndrome based on the theory of pungent flavor promoting

中文摘要英文摘要

目的 探讨基于《备急千金要方》辛味药"辛能行散"理论透皮给药治疗膝骨关节炎(KOA)的临床效果.方法 选取2021年9月—2024年9月就诊的128例KOA寒湿痹阻证患者,以随机数字表法分为西药组和辛味药组,各64例.西药组给予常规西药治疗,辛味药组在西药组基础上基于《备急千金要方》辛味药"辛能行散"理论透皮给药治疗.比较两组临床疗效、中医证候积分、膝关节疼痛程度[视觉模拟评分法(VAS)]、病情严重程度[西安大略和麦克马斯特大学骨关节炎指数(WOMAC)]、炎症因子[白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、前列腺素E2(PGE2)]水平、病情相关指标[Toll样受体-4(TLR-4)、髓样分化因子88(MyD88)]mRNA相对表达量、安全性及复发率.结果 辛味药组总有效率[95.31%(61/64)]较西药组[84.38%(54/64)]高(P<0.05).治疗后,辛味药组各中医证候积分、总分及WOMAC、VAS评分低于西药组(P<0.01).治疗后,辛味药组TNF-α、PGE2、IL-6及TLR-4、MyD88 mRNA相对表达量低于西药组(P<0.01);两组不良反应发生率比较差异无统计学意义(P>0.05).治疗后3、6个月,辛味药组复发率[1.64%(1/61)、3.45%(2/58)]较西药组[12.96%(7/54)、18.18%(8/44)]低(P<0.01).结论 基于《备急千金要方》辛味药"辛能行散"理论透皮给药治疗KOA寒湿痹阻证效果显著,可减轻膝关节疼痛感,改善临床症状,调节TLR-4/MyD88信号通路,抑制炎症反应,降低复发风险,且安全性高.

Objective To investigate the clinical efficacy of transdermal delivery of pungent herbs for knee osteoarthritis(KOA)with cold-dampness bi syndrome based on the theory of pungent flavor promoting movement and dissipation in Beiji Qianjin Yaofang(Essential Prescriptions Worth a Thousand in Gold for Every Emergency).Methods A total of 128 patients with KOA admitted from September 2021 to September 2024 were selected and divided into Western medicine group and pungent herbs group using random number table,with 64 patients in each group.The Western medicine group received conventional Western medicine treatment,while the pungent herbs group received transdermal delivery of pungent herbs based on the theory of pungent flavor promoting movement and dissipation in Beiji Qianjin Yaofang on the basis of the Western medicine group.The clinical efficacy,traditional Chinese medicine(TCM)syndrome score,knee joint pain degree[visual analogue scale(VAS)],disease severity[Western Ontario and McMaster University Osteoarthritis Index(WOMAC)],inflammatory factor levels[interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),prostaglandin E2(PGE2)],disease-related indicators[relative expression of Toll-like receptor-4(TLR-4),myeloid differentiation factor 88(MyD88)mRNA],safety and recurrence rate were compared between the two groups.Results The total effective rate in the pungent herbs group was[95.31%(61/64)],which was higher than that in the Western medicine group[84.38%(54/64)](P<0.05).After treatment,the various TCM syndrome scores and total scores,WOMAC and VAS scores in the pungent herbs group were lower than those in the Western medicine group(P<0.01).After treatment,the relative expression levels of TNF-α,PGE2,IL-6,TLR-4 and MyD88 mRNA in the pungent herbs group were lower than those in the Western medicine group(P<0.01).There was no significant difference in the incidence of adverse reactions between groups(P>0.05).At 3 and 6 months after treatment,the recurrence rate in the pungent herbs group[1.64%(1/61),3.45%(2/58)]was lower than that in the Western medicine group[12.96%(7/54),18.18%(8/44)](P<0.01).Conclusion Transdermal delivery of pungent herbs for KOA with cold-dampness bi syndrome based on the theory of pungent flavor promoting movement and dissipation in Beiji Qianjin Yaofang has a significant efficacy,which can reduce knee pain,improve clinical symptoms,regulate TLR-4/MyD88 signaling pathway,inhibit inflammatory response,reduce the risk of recurrence,and has high safety.

丛文玲;刘春慧;罗文娟;李彦宾;白涵睿

内蒙古医科大学中医学院,呼和浩特 010010内蒙古医科大学中医学院,呼和浩特 010010||内蒙古医科大学附属蒙中医院,呼和浩特 010010内蒙古医科大学中医学院,呼和浩特 010010内蒙古医科大学中医学院,呼和浩特 010010内蒙古医科大学中医学院,呼和浩特 010010

膝骨关节炎备急千金要方辛味药辛能行散西安大略和麦克马斯特大学骨关节炎指数髓样分化因子88复发

knee osteoarthritisBeiji Qianjin Yaofangpungent herbspungent flavor promoting movement and dissipationWestern Ontario and McMaster University Osteoarthritis Indexmyeloid differentiation factor 88recurrence

《临床误诊误治》 2026 (8)

86-91,6

内蒙古自治区自然科学基金项目(2024MS08033)内蒙古自治区卫生健康科技计划项目(202202140)内蒙古医科大学"创客培育项目(101322025108)

10.3969/j.issn.1002-3429.2026.08.015

评论